The independent source for health policy research, polling, and news.
6,101 - 6,120 of 15,227 Results
President Donald Trump called for an end to the "unpleasant surprise" of certain medical bills on Thursday. NPR reporter Selena Simmons-Duffin covered the White House announcement, which featured two patients from the KHN-NPR "Bill of the Month" series.
The savvy “Right to Desire” campaign relies on feminist messages and social media to raise patient awareness about low libido. Addyi, the only drug currently approved to treat it, has shown limited effectiveness.
Despite the broad agreement on the need to address surprise bills, insurers and health care providers oppose the other side’s preferred solutions.
California officials announced a ban on chlorpyrifos, a widely used pesticide that has been linked to lower IQs, lower birth weights and other developmental issues in children, even as the federal government fights to protect it.
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest news about the Trump administration’s effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
Findings released Thursday by the Rand Corp. highlight how reimbursement rates vary nationally and the impact the charges have on the nation’s high cost of health care.
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads — just like side effects.
More Republicans, at the statehouse level, are saying research and results support their endorsement of a once-controversial plan to limit disease among drug users.
A study looked at who gets Suboxone prescriptions and found that whites are almost 35 times more likely to get the addiction treatment than African Americans.
California Gov. Gavin Newsom’s proposal to provide health coverage to unauthorized immigrants ages 19 to 25 would siphon money that four counties currently use for public health efforts such as battling contagious diseases.
America spends about as much on prescription drugs as all the revenues of the three big car makers combined. Tracking where the money goes is hard. PolitiFact has some charts to help.
Two of the most commonly used anesthesia gases are similar medically but worlds apart when it comes to their impact on the planet.
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
In the West and Midwest, 70% of local law enforcement says meth is the bigger threat. It's also a more difficult addiction to treat.
Many plastic surgeons don’t participate in health plans, even when providing emergency care at a hospital. Too often that catches patients off guard.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
A growing mental health crisis among children is exacerbated by a national shortage of child psychiatrists and therapists. It’s either difficult to get, or to afford, an appointment for your child. Here’s some advice that might help.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
In the wake of a KHN investigation, the agency will no longer let device makers file reports of harm outside a widely used public database.
© 2026 KFF